As of May 23, 2025, Albioma SA's estimated intrinsic value ranges from $27.85 to $47.51 per share, depending on the valuation methodology applied.
Valuation Method | Fair Value (USD) | Implied Upside/Downside |
---|---|---|
Discounted Cash Flow (10Y) | $47.51 | +0.8% |
Discounted Cash Flow (5Y) | $27.85 | -40.9% |
Dividend Discount Model (Multi-Stage) | $46.31 | -1.8% |
Dividend Discount Model (Stable) | $33.66 | -28.6% |
Earnings Power Value | $36.34 | -22.9% |
Is Albioma SA (ABIO.PA) undervalued or overvalued?
With the current market price at $47.14, the stock appears to be moderately overvalued.
Intrinsic value represents the "true" worth of a company based on its fundamentals rather than market sentiment. We've employed multiple methodologies to triangulate Albioma SA's intrinsic value, including:
The cost of capital is a critical factor in valuation models, representing the required return for investors.
WACC Component | Low | High |
---|---|---|
Long-term bond rate | 3.0% | 3.5% |
Equity market risk premium | 5.8% | 6.8% |
Adjusted beta | 0.54 | 0.6 |
Cost of equity | 6.2% | 8.1% |
Cost of debt | 4.7% | 10.6% |
Tax rate | 27.4% | 29.5% |
Debt/Equity ratio | 0.66 | 0.66 |
After-tax WACC | 5.1% | 7.8% |
Our DCF model projects cash flows over 5-year and 10-year horizons, with the following key assumptions:
DCF Model | Fair Value | Enterprise Value | % from Terminal Value |
---|---|---|---|
5-Year Growth | $28 | $1,939M | 82.5% |
10-Year Growth | $48 | $2,576M | 70.2% |
5-Year EBITDA | $73 | $3,418M | 90.1% |
10-Year EBITDA | $87 | $3,859M | 80.1% |
The DDM values a company based on its expected future dividend payments. We used two approaches:
EPV assesses a company's value based on its current normalized earnings power, assuming no growth.
EPV Component | Value |
---|---|
Normalized Earnings | $136M |
Discount Rate (WACC) | 7.8% - 5.1% |
Enterprise Value | $1,739M - $2,688M |
Net Debt | $1,036M |
Equity Value | $703M - $1,653M |
Outstanding Shares | 32M |
Fair Value | $22 - $51 |
Selected Fair Value | $36.34 |
Metric | Value |
---|---|
Market Capitalization | $1528M |
Enterprise Value | $2564M |
Trailing P/E | 26.84 |
Forward P/E | 21.92 |
Trailing EV/EBITDA | 11.50 |
Current Dividend Yield | 299.68% |
Dividend Growth Rate (5Y) | 14.94% |
Debt-to-Equity Ratio | 0.66 |
To determine the most reliable intrinsic value estimate, we weigh each valuation method based on:
Valuation Method | Weight | Weighted Value |
---|---|---|
Discounted Cash Flow (10Y) | 30% | $14.25 |
Discounted Cash Flow (5Y) | 25% | $6.96 |
Dividend Discount Model (Multi-Stage) | 20% | $9.26 |
Dividend Discount Model (Stable) | 15% | $5.05 |
Earnings Power Value | 10% | $3.63 |
Weighted Average | 100% | $39.16 |
Based on our comprehensive valuation analysis, Albioma SA's weighted average intrinsic value is $39.16, which is approximately 16.9% below the current market price of $47.14.
Key investment considerations:
Given these factors, we believe Albioma SA is currently moderately overvalued with the potential for long-term appreciation based on the company's growth trajectory and financial strength.